Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / YMAB - Puma's Positive Neratinib Data And Other News: The Good Bad Ugly Of Biopharma

YMAB - Puma's Positive Neratinib Data And Other News: The Good Bad Ugly Of Biopharma

Y-mAbs Therapeutics Inc.
  • Puma Biotechnology reports positive Neratinib Phase III data.
  • Y-mAbs Therapeutics receives FDA rejection for omburtamab BLA.
  • Halozyme Therapeutics fortifies collaboration with Argenx for Enhanze technology.

For further details see:

Puma's Positive Neratinib Data, And Other News: The Good, Bad Ugly Of Biopharma
Stock Information
Company Name: Y-mAbs Therapeutics Inc.
Stock Symbol: YMAB
Market: NASDAQ
Website: ymabs.com
Menu
YMAB YMAB Quote YMAB Short YMAB News YMAB Articles YMAB Message Board
Get YMAB Alerts

News, Short Squeeze, Breakout and More Instantly...